Literature DB >> 25810785

Serum vitamin D and parathyroid hormone profiles in patients with various stages of renal disease.

Abdelgayoum A Abdel-Gayoum1.   

Abstract

BACKGROUND: The prevalence of vitamin D deficiency among Saudi population has increased recently. The social and pathological factors, including kidney disease that may have influenced the vitamin status have not been investigated in the Hail population. AIMS: The present study aims to: (1) investigate changes in the serum vitamin D, parathyroid hormone, serum calcium, and phosphate levels in Saudi patients with kidney disease; and (2) elucidate the other possible physiological factors that may have influence on the vitamin status.
METHODS: A cross-sectional study was carried out in King Khalid Hospital in Hail, Saudi Arabia. The database of kidney disease patients that attended the Kidney Unit between September 2012 and June 2013 was searched and data classified according to the estimated glomerular filtration rate into stages 1-4. Beside the kidney function parameters, serum calcium, phosphorus, vitamin D, and parathyroid hormone were measured.
RESULTS: Out of the 167 patients who visited the kidney unit, the data of 96 patients was included in the study. The results exhibited significant reductions in serum vitamin D level in stage 4 patients by 52.05 per cent with significant increase in the serum PTH level amounting to 3.5-fold. Kidney impairment at stage 4 caused significant increase in the serum phosphate level by 15.74 per cent and the serum calcium by 8.17 per cent. Significant correlations were observed between serum creatinine and Log PTH (r=0.704, p<0.0001) and a negative correlation between creatinine and log vitamin D (r=-0.373, p=0.001).
CONCLUSION: The results exhibited depletion of serum vitamin D concentration accompanied with the development of severe secondary hyperparathyroidism with the progression in kidney disease. The vitamin D deficiency was more prominent in females, older ages, and advanced kidney disease.

Entities:  

Keywords:  Vitamin D; kidney disease; parathyroid hormone

Year:  2015        PMID: 25810785      PMCID: PMC4354022          DOI: 10.4066/AMJ.2015.2252

Source DB:  PubMed          Journal:  Australas Med J        ISSN: 1836-1935


  44 in total

Review 1.  Can vitamin D slow down the progression of chronic kidney disease?

Authors:  Rukshana Shroff; Mandy Wan; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2011-12-10       Impact factor: 3.714

Review 2.  The epithelial calcium channels, TRPV5 & TRPV6: from identification towards regulation.

Authors:  Els den Dekker; Joost G J Hoenderop; Bernd Nilius; René J M Bindels
Journal:  Cell Calcium       Date:  2003 May-Jun       Impact factor: 6.817

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

4.  The effects of changing vitamin D levels on anemia in chronic kidney disease patients: a retrospective cohort review.

Authors:  P T Lac; K Choi; I-A Liu; S Meguerditchian; S A Rasgon; J J Sim
Journal:  Clin Nephrol       Date:  2010-07       Impact factor: 0.975

Review 5.  Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition.

Authors:  M Honasoge; D S Rao
Journal:  Curr Opin Rheumatol       Date:  1995-05       Impact factor: 5.006

6.  Overweight and obesity in the eastern province of Saudi Arabia.

Authors:  Nadira A Al-Baghli; Aqeel J Al-Ghamdi; Khalid A Al-Turki; Ahmad G El-Zubaier; Mahmood M Al-Ameer; Fadel A Al-Baghli
Journal:  Saudi Med J       Date:  2008-09       Impact factor: 1.484

7.  Vitamin D(3) in fat tissue.

Authors:  Miriam Blum; Gregory Dolnikowski; Elias Seyoum; Susan S Harris; Sarah L Booth; James Peterson; Edward Saltzman; Bess Dawson-Hughes
Journal:  Endocrine       Date:  2008-03-13       Impact factor: 3.633

8.  alpha-Klotho as a regulator of calcium homeostasis.

Authors:  Akihiro Imura; Yoshihito Tsuji; Miyahiko Murata; Ryota Maeda; Koji Kubota; Akiko Iwano; Chikashi Obuse; Kazuya Togashi; Makoto Tominaga; Naoko Kita; Ken-ichi Tomiyama; Junko Iijima; Yoko Nabeshima; Makio Fujioka; Ryo Asato; Shinzo Tanaka; Ken Kojima; Juichi Ito; Kazuhiko Nozaki; Nobuo Hashimoto; Tetsufumi Ito; Takeshi Nishio; Takashi Uchiyama; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

9.  Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?

Authors:  Alex J Brown
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12-27       Impact factor: 4.292

10.  Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children.

Authors:  Kumaravel Rajakumar; John D Fernstrom; Michael F Holick; Janine E Janosky; Susan L Greenspan
Journal:  Obesity (Silver Spring)       Date:  2008-01       Impact factor: 5.002

View more
  1 in total

1.  Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study.

Authors:  Laura M G Meems; Frank P Brouwers; Michel M Joosten; Hiddo J Lambers Heerspink; Dick de Zeeuw; Stephan J L Bakker; Ron T Gansevoort; Wiek H van Gilst; Pim van der Harst; Rudolf A de Boer
Journal:  ESC Heart Fail       Date:  2016-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.